such an under the radar stock for the past few years, looks like it's time has finally come.
much to like about the way they go about their business too, steadily building the reputation.
Solid base from 0.40, with a number of products growing market share year on year across several regions it was only a matter of time before the market woke up to this gem, imo
bit of recent history straight from co announcements for any one interested;
26/2/18
Business Update
"Profitability grows, with constant sales,validating changes made to product composition (new low cost Grael ® devices) and the selective outsourcing of production, along with other efficiency gains
US business sales orders 49% higher than H1 FY17
Germany - based DWL experienced a 19% lift in sales compared to H1 FY17
eHealth: Nexus 360: sites continue to be added.
Somfit®consumer sleep device: discussions
continue to progress regarding commercialization activities"
MEG
19 April 2018
"Gordon Haid to head international sales push for new MEG Functional - Brain Scanning Division
Compumedics has overcome earlier MEG system barriers with the Compumedics Neuroscan Orion LifeSpan™’s increased precision coupled with fully - integrated MEG (Curry MEG) “gold standard” brain analysis software.
The new Orion Lifespan™ MEG presents for functional brain imaging today what MRI was to structural or metabolic imaging in the 80’s and beyond.
His deep knowledge of the MEG market, coupled with his extensive business development and sales experience will allow Gordon to significantly strengthen this commercial activation phase for Compumedics/Neuroscan’s new - generation Orion MEG system"
TCD
1/5/18
"DWL, Compumedics’ Germany based business, receives AUD $2.9 million sales order from its long-term distributor in China
New contract re-enforces Compumedics’ strategy
to expand its core business in major global medical device markets
Compumedics has a significant presence in China and has spent almost two decades with our Chinese partners, building a foundation for future growth in one of the world’s most challenging but highest growth markets.
“Compumedics continues to be the number one premium supplier of sleep diagnostic and neurological
research systems in China and is carving out a similar position in Transcranial Doppler Sonography(TCD) systems.
As a result, Compumedics is well positioned to capture growth with all the medical products it sells into the China market.”
25 May 2018
"New three - year distribution contracts with three existing, long - term, China - based, sleep and neuro - diagnostic and monitoring distributors. Underpins Compumedics on-going growth in core products for China, now running at an average of 20% pa, for the last five years"
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)